Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS — Stella

Home/Multiple Sclerosis/Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

View on ClinicalTrials.gov

Recruiting

Back to Multiple Sclerosis trials

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Shirley Ryan AbilityLab, Chicago, Illinois

Key details

Sponsor

Shirley Ryan AbilityLab

Collaborators

National Multiple Sclerosis Society

Enrollment target

~22 participants

Started

February 2025

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.